ClinicalTrials.gg
Active, not recruitingNCT06257589Updated Feb 14, 2024

A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis

An observational study in Diaphragm Issues, Diaphragm; Paralysis, Due to Accidental Section of Phrenic Nerve During Procedure and Breath Shortness, sponsored by Advanced Reconstructive Surgery Alliance. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2024-02-14.

Primary conditionDyspneaRegistry: ParalysisReclassifiedWhy we changed it
Registry
Paralysis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Dyspnea
Why
  1. Paralysis is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Dyspnea.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Advanced Reconstructive Surgery Alliance · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
700
Ages
18 Years to 95 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 214 studies in Dyspnea with a site in United States — 31 open to participants now, 37 under way, 1 of them phase 3. Dyspnea · United States.

Enrollment
7th of 62
700 · median 93
Started
2023
with 13 others
Observational
62 of 214
6 open now
Primary completion
2025-10
later than 5 of 36 live
Registered
185th of 214
by date

Among the 214 studies in Dyspnea with a site in United States, this one is the 7th largest by enrollment of the 62 observational ones that give a count, is one of 14 that started in 2023, is one of 62 observational ones, reaches primary completion later than 5 of the 36 other live ones, and was the 185th registered.

Dyspnea

895 studies on the registry are indexed under Dyspnea; 189 are open to participants now.

Browse Dyspnea studies →

Open to participants now

31 of the 214 studies in Dyspnea with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Dyspnea studies recruiting now, 68 (54%) set no upper age limit and 41 (33%) stop at 75 or younger; 18 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 95 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 214 studies in Dyspnea with a site in United States, or all of them as a file.
02

Study summary

A retrospective chart review to evaluate the safety and efficacy of phrenic nerve reconstruction for diaphragmatic paralysis.

03

Conditions studied

  • Diaphragm Issues
  • Diaphragm; Paralysis, Due to Accidental Section of Phrenic Nerve During Procedure
  • Breath Shortness
  • Diaphragmatic Paralysis

Browse trials for

Keywords

  • Grounded Theory
  • Mixed Methods
  • Chart Review
  • Diaphragmatic Paralysis
04

In context

Dyspnea Reclassified

895 studies on the registry are indexed under Dyspnea; 189 are open to participants now.

This study's enrollment of 700 is above the median of 103 across 272 observational studies indexed under Dyspnea.

Browse Dyspnea studies →

Lead sponsor

Advanced Reconstructive Surgery Alliance is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Compared within Dyspnea, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Paralysis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients who underwent phrenic nerve reconstructive surgery for the treatment of Diaphragmatic Paralysis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who underwent phrenic nerve reconstructive surgery for the treatment of Diaphragmatic Paralysis.

Exclusion criteria

Exclusion Criteria:

  • Age 18 and below.
06

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
700 participants (actual)
Patient registry
No

Groups and cohorts

  • Intrathoracic Approach

    Patients who have undergone the intrathoracic approach of phrenic nerve reconstruction for the treatment of diaphragmatic paralysis. NO INTERVENTION.

  • Cervical Approach

    Patients who have undergone the cervical approach of phrenic nerve reconstruction for the treatment of diaphragmatic paralysis. NO INTERVENTION.

07

What researchers measure

Primary outcomes

  1. Radiographic Position of Diaphragm.

    Radiographic Thoracic Imaging.

    Time frame: Up to 12 Months.

  2. Pulmonary Function.

    Pulmonary Function Test (PFT).

    Time frame: Up to 12 Months.

Secondary outcomes

  1. Health-Related Quality of Life (HRQoL).

    SF-36 / RAND Survey.

    Time frame: Up to 12 Months.

  2. Safety of Phrenic Nerve Reconstruction for Diaphragmatic Paralysis.

    AEs related to the procedure reported in the medical chart.

    Time frame: Up to 24 Months.

08

Study locations

2 sites
09

References and documents

Publications

  • Kaufman MR, Ferro N, Paulin E. Phrenic nerve paralysis and phrenic nerve reconstruction surgery. Handb Clin Neurol. 2022;189:271-292. doi: 10.1016/B978-0-323-91532-8.00003-3. PubMed 36031309 ↗
  • Kaufman MR, Chang EI, Bauer T, Rossi K, Elkwood AI, Paulin E, Jarrahy R. Phrenic Nerve Reconstruction for Effective Surgical Treatment of Diaphragmatic Paralysis. Ann Plast Surg. 2021 Sep 1;87(3):310-315. doi: 10.1097/SAP.0000000000002896. PubMed 34397519 ↗
  • Kaufman MR, Bauer T, Onders RP, Brown DP, Chang EI, Rossi K, Elkwood AI, Paulin E, Jarrahy R. Treatment for bilateral diaphragmatic dysfunction using phrenic nerve reconstruction and diaphragm pacemakers. Interact Cardiovasc Thorac Surg. 2021 May 10;32(5):753-760. doi: 10.1093/icvts/ivaa324. PubMed 33432336 ↗
  • Kaufman MR, Bauer T, Campbell S, Rossi K, Elkwood A, Jarrahy R. Prospective analysis of a surgical algorithm to achieve ventilator weaning in cervical tetraplegia. J Spinal Cord Med. 2022 Jul;45(4):531-535. doi: 10.1080/10790268.2020.1829417. Epub 2020 Oct 15. PubMed 33054689 ↗
  • Kaufman MR, Willekes LJ, Elkwood AI, Rose MI, Patel TR, Ashinoff RL, Colicchio AR. Diaphragm paralysis caused by transverse cervical artery compression of the phrenic nerve: the Red Cross syndrome. Clin Neurol Neurosurg. 2012 Jun;114(5):502-5. doi: 10.1016/j.clineuro.2012.01.048. Epub 2012 Feb 24. PubMed 22366245 ↗
  • Kaufman MR, Elkwood AI, Brown D, Cece J, Martins C, Bauer T, Weissler J, Rezzadeh K, Jarrahy R. Long-Term Follow-Up after Phrenic Nerve Reconstruction for Diaphragmatic Paralysis: A Review of 180 Patients. J Reconstr Microsurg. 2017 Jan;33(1):63-69. doi: 10.1055/s-0036-1588018. Epub 2016 Sep 25. Erratum In: J Reconstr Microsurg. 2017 Jan;33(1):e1-e2. doi: 10.1055/s-0037-1604271. PubMed 27665114 ↗
  • Kaufman MR, Elkwood AI, Colicchio AR, CeCe J, Jarrahy R, Willekes LJ, Rose MI, Brown D. Functional restoration of diaphragmatic paralysis: an evaluation of phrenic nerve reconstruction. Ann Thorac Surg. 2014 Jan;97(1):260-6. doi: 10.1016/j.athoracsur.2013.09.052. Epub 2013 Nov 19. PubMed 24266954 ↗
  • Kaufman MR, Elkwood AI, Rose MI, Patel T, Ashinoff R, Saad A, Caccavale R, Bocage JP, Cole J, Soriano A, Fein E. Reinnervation of the paralyzed diaphragm: application of nerve surgery techniques following unilateral phrenic nerve injury. Chest. 2011 Jul;140(1):191-197. doi: 10.1378/chest.10-2765. Epub 2011 Feb 24. PubMed 21349932 ↗
  • Kaufman MR, Elkwood AI, Rose MI, Patel T, Ashinoff R, Fields R, Brown D. Surgical treatment of permanent diaphragm paralysis after interscalene nerve block for shoulder surgery. Anesthesiology. 2013 Aug;119(2):484-7. doi: 10.1097/ALN.0b013e31829c2f22. No abstract available. PubMed 23838708 ↗
  • Kaufman MR, Elkwood AI, Aboharb F, Cece J, Brown D, Rezzadeh K, Jarrahy R. Diaphragmatic reinnervation in ventilator-dependent patients with cervical spinal cord injury and concomitant phrenic nerve lesions using simultaneous nerve transfers and implantable neurostimulators. J Reconstr Microsurg. 2015 Jun;31(5):391-5. doi: 10.1055/s-0035-1549159. Epub 2015 Apr 13. PubMed 25868155 ↗

Individual participant data

Plan to share: No — No Individual participant data (IPD) will not be shared.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2023 (actual). Primary completion is estimated for Oct 2025, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2024
First posted
Feb 14, 2024
StartActual
Oct 10, 2023
Primary completionEst.
Oct 10, 2025
CompletionEst.
Oct 10, 2026
Last update
Feb 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06257589
Lead sponsor
Advanced Reconstructive Surgery Alliance
Responsible party
Matthew Kaufman, MD (Head of Phrenic Nerve Reconstructive Surgery., Advanced Reconstructive Surgery Alliance) — Principal investigator
First posted
Feb 14, 2024
Start date
Oct 10, 2023
Primary completion
Oct 10, 2025 (estimated)
Completion
Oct 10, 2026 (estimated)
Last update
Feb 14, 2024

Study contacts

Matthew Kaufman, MD
principal investigator · Advanced Reconstructive Surgery Alliance

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion